Immune checkpoint inhibitors have become part of the standard of care for more than 14 different cancer types, including...
A pair of studies presented at the AACR Annual Meeting 2019 demonstrated encouraging clinical outcomes with two different chimeric...
The spectacular sight of the AACR Annual Meeting 2019 Opening Ceremony, held Sunday, March 31, at the Georgia World...
This year, the AACR Annual Meeting, the premier cancer research meeting in the world, is happening at the Georgia...
Immune-related adverse events (irAEs) is the collective term used to describe the side effects that arise in response to...
In 2018, we witnessed significant momentum in several hot areas of cancer research, including immunotherapy and precision medicine. Researchers...
The 41st San Antonio Breast Cancer Symposium, held Dec. 4-8, drew more than 7,500 attendees from more than 90...
In a study published in the AACR’s journal Clinical Cancer Research, a team of scientists from the University of...
Cancer treatments have been, and continue to be in most cases, based on the organ site where the tumor...
This was another spectacular year for the AACR Annual Meeting with its record-breaking attendance of more than 22,500. From...